Bill & Melinda Gates Foundation has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $59.8 Million distributed in 6 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Immunocore Holdings PLC with a value of $19.6M, Vir Biotechnology, Inc. with a value of $13.9M, Bio N Tech Se with a value of $11.9M, Exscientia PLC with a value of $8.11M, and Cure Vac N.V. with a value of $5.43M.

Examining the 13F form we can see an decrease of $22.5M in the current position value, from $82.3M to 59.8M.

Bill & Melinda Gates Foundation is based out at Seattle, WA

Below you can find more details about Bill & Melinda Gates Foundation portfolio as well as his latest detailed transactions.

Portfolio value $59.8 Million
Healthcare: $59.8 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 6
  • Current Value $59.8 Million
  • Prior Value $82.3 Million
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Bill & Melinda Gates Foundation Portfolio

Follow Bill & Melinda Gates Foundation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bill & Melinda Gates Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Bill & Melinda Gates Foundation with notifications on news.